Company news
CanaQuest Medical Corporation news in 2022
CanaQuest Medical Corporation's news releases, calls and decks from 2022, newest first.
CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD
December 7, 2022
Canaquest Launches Mentanine (R) (Cannabidiol + IP Formula) in the US via WWW.CANAQUESTSTORE.COM, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD
September 7, 2022
Decks in 2022
- Investor Presentation (March 2022)
Investor deck · 15 slides · March 2022
- Investor Presentation (February 2022)
Investor deck · 17 slides · February 2022